(19)
(11) EP 1 732 580 A2

(12)

(88) Date of publication A3:
26.10.2006

(43) Date of publication:
20.12.2006 Bulletin 2006/51

(21) Application number: 04809990.7

(22) Date of filing: 15.10.2004
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61K 39/395(2006.01)
A01N 37/18(2006.01)
A01N 65/00(2006.01)
A61K 31/70(2006.01)
A01N 63/00(2006.01)
A01N 43/04(2006.01)
(86) International application number:
PCT/US2004/034693
(87) International publication number:
WO 2005/067460 (28.07.2005 Gazette 2005/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 24.12.2003 US 532696 P
18.08.2004 US 602588 P
01.10.2004 US 615548 P
07.10.2004 US 617564 P

(71) Applicant: MEDIMMUNE, INC.
Gaithersburg, MD 20878 (US)

(72) Inventor:
  • KINCH, Michael, S.
    Laytonsville, MD 20882 (US)

(74) Representative: Chapman, Paul Gilmour 
Marks & Clerk 19 Royal Exchange Square
Glasgow G1 3AE
Glasgow G1 3AE (GB)

   


(54) EPHA2 VACCINES